Effects of online intervention for depression on mood and positive symptoms in schizophrenia

Schizophrenia Research

Volumn 175, Issue 1-3, 2016, Pages 216-222

  Moritz, Steffen ^a   Schröder, Johanna ^a   Klein, Jan Philipp ^b   Lincoln, Tania M ^c   Andreou, Christina ^a   Fischer, Anja ^d   Arlt, Sönke ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

Depression; Online intervention; Psychosis; Schizophrenia; Self help

Indexed keywords

ADULT; ARTICLE; BEHAVIOR ASSESSMENT; CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEPRESSION; EFFECT SIZE; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; ONLINE INTERVENTION; ONLINE SYSTEM; OUTCOME ASSESSMENT; PARANOIA CHECKLIST; PATIENT COMPLIANCE; PATIENT HEALTH QUESTIONNAIRE 9; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SELF REPORT; SINGLE BLIND PROCEDURE; TELEPHONE INTERVIEW; TEST RETEST RELIABILITY; AFFECT; ANALYSIS OF VARIANCE; COMPUTER ASSISTED THERAPY; INTERNET; PATIENT DROPOUT; PSYCHOLOGICAL INTERVIEW; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; AFFECT; ANALYSIS OF VARIANCE; DEPRESSION; FEMALE; HUMANS; INTERNET; INTERVIEW, PSYCHOLOGICAL; MALE; PATIENT DROPOUTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SINGLE-BLIND METHOD; SURVEYS AND QUESTIONNAIRES; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84969506417     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2016.04.033     Document Type: Article

References (54)

1. Alvarez-Jimenez, M., Alcazar-Corcoles, M.A., Gonzalez-Blanch, C., Bendall, S., McGorry, P.D., Gleeson, J.F., Online, social media and mobile technologies for psychosis treatment: a systematic review on novel user-led interventions. Schizophr. Res. 156 (2014), 96–106.
2. Bechdolf, A., Klingberg, S., Psychotherapy of schizophrenia: not a problem of evidence, but a problem of implementation (Psychotherapie bei schizophrenen Störungen: Kein Evidenz-, sondern ein Implementierungsproblem). Psychiatr. Prax. 41 (2014), 8–10.
3. Beck, A.T., Steer, R.A., Beck Depression Inventory Manual. 1993, Psychological Corporation, San Antonio.
4. Borm, G.F., Fransen, J., Lemmens, W.A., A simple sample size formula for analysis of covariance in randomized clinical trials. J. Clin. Epidemiol. 60 (2007), 1234–1238.
5. Buckley, P.F., Miller, B.J., Lehrer, D.S., Castle, D.J., Psychiatric comorbidities and schizophrenia. Schizophr. Bull. 35 (2009), 383–402.
6. Burckhardt, K., Why it is Difficult to Distinguish between Negative and Depressive Symptomatology in Schizophrenia. 2012, University of Hamburg, Hamburg, Germany.
7. Byrne, R., Davies, L., Morrison, A.P., Priorities and preferences for the outcomes of treatment of psychosis: a service user perspective. Psychosis 3 (2010), 210–217.
8. Cuijpers, P., Donker, T., Johansson, R., Mohr, D.C., Van Straten, A., Andersson, G., Self-guided psychological treatment for depressive symptoms: a meta-analysis. PLoS One, 6, 2011, e21274.
9. Fischer, A., Schröder, J., Vettorazzi, E., Wolf, O.T., Pöttgen, J., Lau, S., Heesen, C., Moritz, S., Gold, S.M., An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial. Lancet Psychiatry 2 (2015), 217–223.
10. Freeman, D., Garety, P., Advances in understanding and treating persecutory delusions: a review. Soc. Psychiatry Psychiatr. Epidemiol. 49 (2014), 1179–1189.
11. Freeman, D., Garety, P., Fowler, D., Kuipers, E., Dunn, G., Bebbington, P., Hadley, C., The London-East Anglia randomized controlled trial of cognitive-behaviour therapy for psychosis. IV: Self-esteem and persecutory delusions. Br. J. Clin. Psychol. 37 (1998), 415–430.
12. Freeman, D., Garety, P.A., Bebbington, P.E., Smith, B., Rollinson, R., Fowler, D., Kuipers, E., Ray, K., Dunn, G., Psychological investigation of the structure of paranoia in a non-clinical population. Br. J. Psychiatry 186 (2005), 427–435.
13. Fusar-Poli, P., Nelson, B., Valmaggia, L., Yung, A.R., McGuire, P.K., Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr. Bull. 40 (2014), 120–131.
14. Garety, P.A., Kuipers, E., Fowler, D., Freeman, D., Bebbington, P.E., A cognitive model of the positive symptoms of psychosis. Psychol. Med. 31 (2001), 189–195.
15. Gilbody, S., Richards, D., Brealey, S., Hewitt, C., Screening for depression in medical settings with the patient health questionnaire (PHQ): a diagnostic meta-analysis. J. Gen. Intern. Med. 22 (2007), 1596–1602.
16. Häfner, H., Maurer, K., an der Heiden, W., ABC schizophrenia study: an overview of results since 1996. Soc. Psychiatry Psychiatr. Epidemiol. 48 (2013), 1021–1031.
17. Hautzinger, M., Brähler, M., Allgemeine Depressionsskala (ADS) [General Depression Scale]. 1993, Hogrefe, Göttingen.
18. Hor, K., Taylor, M., Suicide and schizophrenia: a systematic review of rates and risk factors. J. Psychopharmacol. 24 (2010), 81–90.
19. Jaspers, K., Allgemeine Psychopathologie [General Psychopathology]. 1973, Springer, Berlin (Germany).
20. Johansson, R., Andersson, G., Internet-based psychological treatments for depression. Expert. Rev. Neurother. 12 (2012), 861–870.
21. Karamatskos, E., Mulert, C., Lambert, M., Naber, D., Subjective well-being of patients with schizophrenia as a target of drug treatment. Curr. Pharm. Biotechnol. 13 (2012), 1490–1499.
22. Karow, A., Pajonk, F.G., Reimer, J., Hirdes, F., Osterwald, C., Naber, D., Moritz, S., The dilemma of insight into illness in schizophrenia: self- and expert-rated insight and quality of life. Eur. Arch. Psychiatry Clin. Neurosci. 258 (2008), 152–159.
23. Kasanin, J., The acute schizoaffective psychoses. Am. J. Psychiatr. 90 (1933), 97–126.
24. Kay, S.R., Opler, L.A., Lindenmayer, J.P., The positive and negative syndrome scale (PANSS): rationale and standardisation. Br. J. Psychiatry 155:Suppl. 7 (1989), 59–67.
25. Kenward, M.G., Roger, J.H., Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53 (1997), 983–997.
26. Kesting, M.L., Lincoln, T.M., The relevance of self-esteem and self-schemas to persecutory delusions: a systematic review. Compr. Psychiatry 54 (2013), 766–789.
27. Kishi, T., Iwata, N., Meta-analysis of noradrenergic and specific serotonergic antidepressant use in schizophrenia. Int. J. Neuropsychopharmacol. 17 (2014), 343–354.
28. Kishi, T., Hirota, T., Iwata, N., Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials. Eur. Arch. Psychiatry Clin. Neurosci. 263 (2013), 633–641.
29. Kraepelin, E., Psychiatrie. Ein Lehrbuch für Studierende Und Aerzte [Psychiatry. A Textbook for Students and Physicians]. 1899, J. A. Barth, Leipzig.
30. Kroenke, K., Spitzer, R.L., Williams, J.B., The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med. 16 (2001), 606–613.
31. Kuck, J., Zisook, S., Moranville, J.T., Heaton, R.K., Braff, D.L., Negative symptomatology in schizophrenic outpatients. J. Nerv. Ment. Dis. 180 (1992), 510–515.
32. Leucht, S., Komossa, K., Rummel-Kluge, C., Corves, C., Hunger, H., Schmid, F., Asenjo Lobos, C., Schwarz, S., Davis, J.M., A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am. J. Psychiatr. 166 (2009), 152–163.
33. Lincoln, T.M., Lüllmann, E., Rief, W., Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophr. Bull. 33 (2007), 1324–1342.
34. Lincoln, T.M., Peter, N., Schafer, M., Moritz, S., From stress to paranoia: an experimental investigation of the moderating and mediating role of reasoning biases. Psychol. Med. 40 (2010), 169–171.
35. Lincoln, T.M., Mobius, C., Huber, M.T., Nagel, M., Moritz, S., Frequency and correlates of maladaptive responses to paranoid thoughts in patients with psychosis compared to a population sample. Cogn. Neurodyn. 19 (2014), 509–526.
36. Moritz, S., Veckenstedt, R., Randjbar, S., Vitzthum, F., Karow, A., Lincoln, T.M., Course and determinants of self-esteem in people diagnosed with schizophrenia during psychiatric treatment. Psychosis 2 (2010), 144–153.
37. Moritz, S., Voigt, M., Kother, U., Leighton, L., Kjahili, B., Babur, Z., Jungclaussen, D., Veckenstedt, R., Grzella, K., Can virtual reality reduce reality distortion? Impact of performance feedback on symptom change in schizophrenia patients. J. Behav. Ther. Exp. Psychiatry 45 (2014), 267–271.
38. Moritz, S., Endlich, L., Mayer, H., Andreou, C., Ramdani, N., Petermann, F. & Balzan, R. P. (in press-a). The benefits of doubt: cognitive bias correction reduces hasty decision-making in schizophrenia. Cogn. Ther. Res.
39. Moritz, S., Berna, F., Jaeger, S., Westermann, S. & Nagel, M. (in press-b). The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis. Eur. Arch. Psychiatry Clin. Neurosci.
40. Naber, D., Karow, A., Good tolerability equals good results: the patient's perspective. Eur. Neuropsychopharmacol. 11:Suppl. 4 (2001), S391–S396.
41. Peralta, V., Cuesta, M.J., Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res. 53 (1994), 31–40.
42. Radloff, L.S., The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1 (1977), 385–401.
43. Richards, D., Richardson, T., Computer-based psychological treatments for depression: a systematic review and meta-analysis. Clin. Psychol. Rev. 32 (2012), 329–342.
44. Santor, D.A., Ascher-Svanum, H., Lindenmayer, J.P., Obenchain, R.L., Item response analysis of the positive and negative syndrome scale. BMC Psychiatry, 7, 2007, 66.
45. Schneider, K., Clinical Psychopathology. 1959, Grune and Stratton, New York.
46. Schröder, J., Brückner, K., Fischer, A., Lindenau, M., Köther, U., Vettorazzi, E., Moritz, S., Efficacy of a psychological online intervention for depression in people with epilepsy: a randomized controlled trial. Epilepsia 55 (2014), 2069–2076.
47. Shafran, R., Clark, D.M., Fairburn, C.G., Arntz, A., Barlow, D.H., Ehlers, A., Freeston, M., Garety, P.A., Hollon, S.D., Ost, L.G., Salkovskis, P.M., Williams, J.M.G., Wilson, G.T., Mind the gap: improving the dissemination of CBT. Behav. Res. Ther. 47 (2009), 902–909.
48. Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., Dunbar, G.C., The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59:Suppl. 20 (1998), 22–33.
49. Spek, V., Cuijpers, P., Nyklicek, I., Riper, H., Keyzer, J., Pop, V., Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: a meta-analysis. Psychol. Med. 37 (2007), 319–328.
50. Sterk, B., Winter van Rossum, I., Muis, M., de Haan, L., Priorities, satisfaction and treatment goals in psychosis patients: an online consumer's survey. Pharmacopsychiatry 46 (2013), 88–93.
51. Suzuki, T., Which rating scales are regarded as ‘the standard’ in clinical trials for schizophrenia? A critical review. Psychopharmacol. Bull. 44 (2011), 18–31.
52. Van der Gaag, M., Hoffman, T., Remijsen, M., Hijman, R., de Haan, L., van Meijel, B., van Harten, P.N., Valmaggia, L., de Hert, M., Cuijpers, A., Wiersma, D., The five-factor model of the positive and negative syndrome scale II: a ten-fold cross-validation of a revised model. Schizophr. Res. 85 (2006), 280–287.
53. Walker, C., Delusion: what did jaspers really say?. Br. J. Psychiatry 159:Suppl. 14 (1991), 94–103.
54. Wykes, T., Steel, C., Everitt, B., Tarrier, N., Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr. Bull. 34 (2008), 523–537.